Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6df6a18e06ae0e6132770a6504815566 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 |
filingDate |
2017-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec27b508d393c66f57399587103d1d4c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fea6f28212ac304af5989c025dc0f6a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b64ca8a7cb6fc1ae43e95522ee638de6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_349812a979d965782b130b974841ba8c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7ceaab05fc45a605736b1368aae7f36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_add04a811c2f40407ea062b587be52dc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23c9ef6887b214795023f1d5d5bd1f10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ff5e4ee064e398925ea0e41f191dd28 |
publicationDate |
2020-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10696666-B2 |
titleOfInvention |
Pharmaceutical compounds |
abstract |
A compound which is an arylimidazolyl isoxazole of formula (I): (Formula (I)) or a pharmaceutically acceptable salt thereof. The compound has activity in modulating the activity of p300 and/or CBP and is used to treat cancer, particularly prostate cancer. |
priorityDate |
2016-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |